200 related articles for article (PubMed ID: 29329575)
1. MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer.
Yu SJ; Yang L; Hong Q; Kuang XY; Di GH; Shao ZM
BMC Cancer; 2018 Jan; 18(1):74. PubMed ID: 29329575
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
4. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
[TBL] [Abstract][Full Text] [Related]
5. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
6. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
7. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1.
Zhang CM; Zhao J; Deng HY
J Biomed Sci; 2013 Oct; 20(1):79. PubMed ID: 24152184
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
[TBL] [Abstract][Full Text] [Related]
9. 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells.
Zhang C; Zhao J; Deng H
Mol Cell Biochem; 2013 Jul; 379(1-2):201-11. PubMed ID: 23568502
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
Liu F; Kong X; Lv L; Gao J
Cancer Lett; 2015 Apr; 359(2):288-98. PubMed ID: 25633840
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer.
Wu ZH; Tao ZH; Zhang J; Li T; Ni C; Xie J; Zhang JF; Hu XC
Tumour Biol; 2016 Jun; 37(6):7245-54. PubMed ID: 26666820
[TBL] [Abstract][Full Text] [Related]
12. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming.
Nguyen PNN; Choo KB; Huang CJ; Sugii S; Cheong SK; Kamarul T
Stem Cell Res Ther; 2017 Sep; 8(1):214. PubMed ID: 28962647
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer.
Lee JW; Guan W; Han S; Hong DK; Kim LS; Kim H
Cancer Sci; 2018 May; 109(5):1404-1413. PubMed ID: 29575368
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p.
Wang M; Qiu R; Yu S; Xu X; Li G; Gu R; Tan C; Zhu W; Shen B
Int J Oncol; 2019 Jan; 54(1):326-338. PubMed ID: 30365045
[TBL] [Abstract][Full Text] [Related]
15. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.
Eades G; Yao Y; Yang M; Zhang Y; Chumsri S; Zhou Q
J Biol Chem; 2011 Jul; 286(29):25992-6002. PubMed ID: 21596753
[TBL] [Abstract][Full Text] [Related]
16. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
17. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin.
Han B; Huang J; Han Y; Hao J; Wu X; Song H; Chen X; Shen Q; Dong X; Pang H; Cai L
Int J Biol Macromol; 2019 Mar; 125():544-556. PubMed ID: 30537505
[TBL] [Abstract][Full Text] [Related]
18. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
Wang X; Zhu J
Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
[TBL] [Abstract][Full Text] [Related]
19. Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p.
Hu K; Liu X; Li Y; Li Q; Xu Y; Zeng W; Zhong G; Yu C
Med Sci Monit; 2020 Aug; 26():e922253. PubMed ID: 32756532
[TBL] [Abstract][Full Text] [Related]
20. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer.
Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W
Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
